Cambrian BioPharma Inc

Form D Filings

Location
New York, NY
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001797409
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
1/13/2025 Option to Acquire, Other $15,330,232 $23,022,065 $37,602,297 $14,580,232 6/2/2023 1/10/2025 D/A 000089706925000101
12/22/2023 Other $7,691,833 $7,691,833 $40,000,000 $32,308,167 6/2/2023 12/22/2023 D 000089706923001843
12/2/2021 Equity, Option to Acquire $92,209,653 $92,209,653 $100,775,000 $8,565,347 10/13/2021 12/1/2021 D 000089706921000581
5/6/2021 Equity, Debt, Option to Acquire $28,434,938 $28,434,938 $28,434,938 $0 10/20/2020 5/6/2021 D 000089706921000216
1/27/2020 Equity, Option to Acquire, Security to be Acquired $4,750,000 $4,750,000 $4,750,000 $0 10/29/2019 1/17/2020 D 000089706920000054